3min chapter

The Foresight Institute Podcast cover image

Nir Barzilai | Targeting Aging with Metformin

The Foresight Institute Podcast

CHAPTER

Introduction

Neobazilai: We're trying to see which other FDA-approved drugs can be used immediately in a clinical trial based on a neuroscience guided approach. He says the bottom line of neuroscience is that when you target one of those hallmarks, you affect others. The short Taim trial serves as a data springboard for the whole longevity field and may move the FDA closer to accepting clinical trials that target mechanisms of aging rather than specific named age-related condition.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode